non-small cell lung cancer

Research in Review

Kidney Cancer Pulmonary Metastases May Hide Primary Lung Cancer Diagnosis

03/27/2017

JCP Editors

Primary non-small cell lung cancer (NSCLC) may be underdiagnosed in patients with metastatic renal cell carcinoma, according to new research. ----- Related Content Leptomeningeal Metastases More Common in EGFR+...

...

03/27/2017

Journal of Clinical Pathways

Research in Review

Hypersensitivity Reactions Present Clinical, Economic Burden for Patients With NSCLC

03/24/2017

JCP Editors

Patients with non-small cell lung cancer (NSCLC) who develop hypersensitivity reactions to first-line chemotherapy are faced with increasing clinical burden and rising costs, according to research presented at the...

...

03/24/2017

Journal of Clinical Pathways

Research in Review

Multikinase Inhibitors Ineffective in Treating RET-Rearranged NSCLC

03/17/2017

JCP Editors

Overall response rate (ORR) is low for patients with non-small cell lung cancer (NSCLC) with RET rearrangements after targeted therapy, according to research published in the Journal of Clinical Oncology (March 13,...

...

03/17/2017

Journal of Clinical Pathways

Research in Review

Study: Newer NSCLC Therapies Have Limited Real-World Survival Benefit, High Costs

02/14/2017

JCP Editors

Therapies recently approved to treat advanced-stage non-small cell lung cancer (NSCLC) confer an average of 1.5-month survival increase and an $8,000 increase in outpatient spending per patient, according to a study...

...

02/14/2017

Journal of Clinical Pathways

Research in Review

Comparative Effectiveness Study Identifies Best Therapy Regimens for Patients With NSCLC

02/02/2017

JCP Editors

A new study comparing first-line therapies for patients with advanced non-small cell lung cancer (NSCLC) suggests a survival advantage of one treatment regimen in younger patients, published in the Journal of Managed...

A new...

02/02/2017

Journal of Clinical Pathways

Research in Review

Anxiety Increases Risk of Mortality for Patients With NSCLC

01/31/2017

JCP Editors

Patients with newly-diagnosed non-small cell lung cancer (NSCLC) who experience anxiety are at a higher risk of cancer-specific mortality, according to research published in the Journal of Pain and Symptom...

...

01/31/2017

Journal of Clinical Pathways

Research in Review

Treatment Advances for Advanced-Stage NSCLC Have Increased Survival

01/05/2017

JCP Editors

Shifts in treatments of advanced-stage non-small cell lung cancer (NSCLC) have resulted in survival and spending gains over time, according to a report published in the Journal of Clinical Oncology. ----- Related...

Shifts...

01/05/2017

Journal of Clinical Pathways

Research in Review

Varying Toxicities Between EGFR-TKIs for Treatment of NSCLC

12/29/2016

JCP Editors

Varying degrees of toxicity risks between different epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) can help inform treatment decisions for individual patients with non-small cell lung...

...

12/29/2016

Journal of Clinical Pathways

Research in Review

SBRT Efficacy May Depend on Lung Cancer Histologic Classification

12/28/2016

JCP Editors

Patients with early-stage non-small cell lung cancer (NSCLC) may be more or less responsive to stereotactic body radiation therapy (SBRT) based upon histological classification, according to a study published in the...

...

12/28/2016

Journal of Clinical Pathways

Research in Review

First-Line Pembrolizumab for NSCLC Improves HRQoL Versus Chemotherapy

12/08/2016

JCP Editors

Patients with early stage metastatic non-small cell lung cancer (NSCLC) whose tumors express high levels of PD-L1 have improved quality of life with pembrolizumab treatment versus standard of care platinum-containing...

...

12/08/2016

Journal of Clinical Pathways